These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2414592)

  • 1. In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644.
    Rogg H; Criscione L; Truog A; Meier M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S31-7. PubMed ID: 2414592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644.
    Hattori Y; Nakaya H; Tohse N; Kanno M
    J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues.
    Nakaya H; Hattori Y; Tohse N; Kanno M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):421-30. PubMed ID: 2430192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain.
    Janis RA; Rampe D; Sarmiento JG; Triggle DJ
    Biochem Biophys Res Commun; 1984 May; 121(1):317-23. PubMed ID: 6203531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
    Ishii K; Taira N; Yanagisawa T
    Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAY K 8644, a 1,4-dihydropyridine Ca2+ channel activator: dissociation of binding and functional effects in brain synaptosomes.
    Rampe D; Janis RA; Triggle DJ
    J Neurochem; 1984 Dec; 43(6):1688-92. PubMed ID: 6208338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
    Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
    Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent.
    Thomas G; Chung M; Cohen CJ
    Circ Res; 1985 Jan; 56(1):87-96. PubMed ID: 2578336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels.
    Franckowiak G; Bechem M; Schramm M; Thomas G
    Eur J Pharmacol; 1985 Aug; 114(2):223-6. PubMed ID: 2412855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow channel calcium activators, a new group of pharmacological agents.
    Preuss KC; Gross GJ; Brooks HL; Warltier DC
    Life Sci; 1985 Oct; 37(14):1271-8. PubMed ID: 2413326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants.
    Schramm M; Thomas G; Towart R; Franckowiak G
    Arzneimittelforschung; 1983; 33(9):1268-72. PubMed ID: 6196037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the voltage-dependent Ca2+ channel in rat heart cells by dihydropyridine derivatives.
    Renaud JF; Méaux JP; Romey G; Schmid A; Lazdunski M
    Biochem Biophys Res Commun; 1984 Nov; 125(1):405-12. PubMed ID: 6210086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel 'agonist' BAY K 8644 inhibits calcium antagonist binding to brain and PC12 cell membranes.
    Greenberg DA; Cooper EC; Carpenter CL
    Brain Res; 1984 Jul; 305(2):365-8. PubMed ID: 6204725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel activation in vascular smooth muscle by BAY K 8644.
    Su CM; Swamy VC; Triggle DJ
    Can J Physiol Pharmacol; 1984 Nov; 62(11):1401-10. PubMed ID: 6210137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
    Bellemann P
    J Recept Res; 1984; 4(1-6):571-85. PubMed ID: 6084713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel activation: a different type of drug action.
    Freedman SB; Miller RJ
    Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5580-3. PubMed ID: 6206501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 1,4-dihydropyridine (Bay K 8644) facilitates calcium-dependent [3H]noradrenaline release from PC 12 cells.
    Albus U; Habermann E; Ferry DR; Glossmann H
    J Neurochem; 1984 Apr; 42(4):1186-9. PubMed ID: 6199462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.
    Spedding M; Berg C
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):69-75. PubMed ID: 6083458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium entry activators: distinct sites of dihydropyridine and aminopyridine action.
    Greenberg DA; Cooper EC; Carpenter CL
    Neurosci Lett; 1984 Sep; 50(1-3):279-82. PubMed ID: 6208517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
    Thomas G; Gross R; Schramm M
    J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.